Intelligence Β· Patent portfolio
Teva Pharma Patents
Full USPTO pharma patent portfolio for Teva Pharma β grant dates, expiration, and drug cross-links.
- Patents
- 454
- Expiring β€24m
- 49
Quick answer
Teva Pharma has 454 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 49 expire within 24 months β use filters for patent-cliff planning.
-
US 7001919
Forms of pravastatin sodium
expired -
US 6992194
Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms
expired -
US 6987175
Processes for preparing clarithromycin polymorphs
expired -
US 6956060
Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
expired -
US 6936731
Pravastatin sodium substantially free of pravastatin lactone and epi-pravastatin, and compositions containing same
expired -
US 6936720
Method for preparing benzisoxazole methane sulfonyl chloride and its amidation to form zonisamide
expired -
US 6930186
Process for the preparation of paroxetine substantially free of alkoxy impurities
expired -
US 6909004
Method for the purification of lansoprazole
expired -
US 6884888
Process for the production of N-[3-(3-cyanopyrazolo[1,5-a] pyrimidin-7-yl) phenyl]-N-ethylacetamide (zaleplon)
expired -
US 6881420
Compositions and dosage forms for gastric delivery of irinotecan and methods of treatment that use it to inhibit cancer cell proliferation
expired -
US 6861553
Process for preparing nateglinide and intermediates thereof
expired -
US 6861426
Crystal forms of lamotrigine and processes for their preparations
expired -
US 6858652
Sertraline hydrochloride polymorphs, processes for preparing them, compositions containing them and methods of using them
expired -
US 6849737
Synthesis and purification of valacyclovir
expired -
US 6849736
Crystalline forms of valacyclovir hydrochloride
expired -
US 6849120
Oxidation method for preparing highly pure modafinil, crystalline forms of modafinil, and methods of preparing the crystalline forms
expired -
US 6806373
Process for preparing leflunomide form I
expired -
US 6800759
Racemization and enantiomer separation of clopidogrel
expired -
US 6774230
Methods for the preparation of mirtazapine intermediates
expired -
US 6764997
Stabilized azithromycin compositions
expired -
US 6750341
Preparation of risperidone
expired -
US 6737411
Racemization and enantiomer separation of clopidogrel
expired -
US 6723855
Method for synthesizing leflunomide
expired -
US 6710184
Crystalline solids of carvedilol and processes for their preparation
expired -
US 6703424
Dispersible compositions containing L-DOPA ethyl ester
expired -
US 6699997
Carvedilol
expired -
US 6696601
Hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical compositions thereof
expired -
US 6696600
L-DOPA ethyl ester salts and uses thereof
expired -
US 6689384
Stable pergolide mesylate and process for making same
expired -
US 6670478
Process for preparing torsemide intermediate
expired -
US 6635765
Processes for preparing torsemide intermediate
expired -
US 6630514
Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
expired -
US 6624292
Processes for preparing clarithromycin polymorphs
expired -
US 6610718
Processes for making- and a new crystalline form of- leflunomide
expired -
US 6605636
Atorvastatin hemi-calcium form VII
expired -
US 6599884
Processes for preparing clarithromycin polymorphs and novel polymorph IV
expired -
US 6600073
Methods for preparation of sertraline hydrochloride polymorphs
expired -
US 6592869
Vaccine composition and method of using the same
expired -
US 6576764
Synthesis and crystallization of piperazine ring-containing compounds
expired -
US 6569459
Method of administration of paclitaxel-plasma protein formulation
expired -
US 6558659
Stable pharmaceutical compositions containing 7-substituted-3,5-dihydroxyheptanoic acids or 7-substituted-3,5-dihydroxyheptenoic acids
expired -
US 6555585
Use of derivatives of valproic acid and 2-valproenic acid amides for the treatment of mania in bipolar disorder
expired -
US 6545149
Synthesis and crystallization of piperazine ring-containing compounds
expired -
US 6541001
Vaccine composition and method of using the same
expired -
US 6538025
Aminoindan derivatives
expired -
US 6531509
Stable gabapentin containing more than 20 ppm of chlorine ion
expired -
US 6528661
Hydrolysis of [R(R*,R*)]-2-(4-fluorophenyl)-&bgr;,&dgr;-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino) carbonyl]-1H-pyrrole-1-heptanoic acid esters with calcium hydroxide
expired -
US 6528685
Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives
expired
Frequently asked questions
How many patents does Teva Pharma have?
454 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Teva Pharma patents expire?
49 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.
Where does this data come from?
USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.
Data attribution: Data sources Β· Patent directory